title: Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.
abstract: Efficacy studies of investigational HIV vaccines require enrollment of individuals at 'high risk' for HIV. This paper examines participation in HIV vaccine trials among women at 'high risk' for HIV acquisition. In-depth interviews were conducted with 17 African-American women who use crack cocaine and/or exchange sex for money/drugs to elicit attitudes toward medical research and motivators and deterrents to HIV vaccine trial participation. Interviews were digitally recorded and transcribed; data were coded and compiled into themes. Most women expressed favorable attitudes toward medical research in general. Motivators for trial participation included compensation; personal benefits including information, social services, and the possibility that the trial vaccine could prevent HIV; and altruism. Deterrents included: dislike of needles; distrust; concern about future consequences of participating. In addition, contingencies, care-giving responsibilities, and convenience issues constituted barriers which could impede participation. Respondents described varied, complex perspectives, and individual cases illustrate how these themes played out as women contemplated trial participation. Understanding factors which influence vaccine research participation among women at 'high risk' can aid sites to tailor recruitment procedures to local contexts. Concerns about future reactions can be addressed through sustained community education. Convenience barriers can be ameliorated by providing rides to study visits when necessary, and/or conducting study visits in accessible neighborhood locations. Women in this sample thought carefully about enrolling in HIV vaccine trials given the structural constraints within which they lived. Further research is needed regarding structural factors which influence personal agency and individuals' thinking about research participation.
authors.affiliation: HIV/AIDS Prevention Research Division, University of Pennsylvania, 3535 Market Street, Suite 4000, Philadelphia, PA 19104, USA. chelseav@mail.med.upenn.edu
authors.forename: Chelsea D
authors.initials: CD
authors.lastname: Voytek
authors.forename: Kevin T
authors.initials: KT
authors.lastname: Jones
authors.forename: David S
authors.initials: DS
authors.lastname: Metzger
mesh_terms: D016915:AIDS Vaccines / Q000008:administration & dosage*; D000328:Adult; D001741:Black or African American / Q000523:psychology; D000533:Altruism; D002755:Choice Behavior; D002986:Clinical Trials as Topic; D005260:Female; D017144:Focus Groups; D006678:HIV / Q000472:pathogenicity; D015658:HIV Infections / Q000517:prevention & control* / Q000821:virology; D006801:Humans; D007407:Interviews as Topic; D009042:Motivation; D010358:Patient Participation / Q000523:psychology*; D012307:Risk Factors; D011477:Sex Work; D011795:Surveys and Questionnaires
chemical_list: D016915:AIDS Vaccines